B01 – Building Global Resilience Locally

Our world is rapidly changing with recent global events such as the election of Donald Trump, Brexit, the Trans-Pacific Partnership Agreement (TPP) generating major shifts in our overarching geopolitical environment. What are the high-level, strategic ramifications of these events on the medicinal technology and pharmaceutical sector in Australia? How is research, development and access to medicines, medical technology and health care evolving in response to these global shifts.  As senior executives, how do you respond to the resulting changes in order to maintain the relevance of your company/role for the foreseeable future?